Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-8682

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-8682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

This text mentions venlafaxine hydrochloride, a medication used to treat depression, anxiety disorders, and panic disorders. It belongs to a class of medications known as selective serotonin and norepinephrine reuptake inhibitors (SNRIs).*

FDA Label Image

Image-02 (Image 02)

This document contains information related to special populations such as patients with hepatic impairment, poor/extensive metabolizers, individuals aged over 80 years, and gender differences. It also mentions the impact of renal impairment and CYP2D6 polymorphism on drug metabolism. Additionally, it includes data on fold change, confidence intervals, analyte levels, and changes relative to reference values. The document appears to focus on the pharmacokinetics of a specific drug (possibly venlafaxine) in various population groups.*

FDA Label Image

Image-03 (Image 03)

This text seems to be a list showing the PK Fold Change and 90% CI values of various drugs when interacting with venlafaxine. The list includes information on drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavie, metoprolol, imipramine, and lithium, specifying their Cmax, AUC, and other parameters when interacting with venlafaxine in different metabolic states (CYP2D6 EM's, CYP2D6 PM's). The text also mentions a reference value for comparison.*

FDA Label Image

Image-04 (Image 04)

This text seems to list a variety of interacting drugs, such as Ethanol, Diazepam, Alprazolam, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, Lithium, and their related active moieties. The document also mentions Fold Change and 90% CI for the drugs listed. It provides valuable information on drug interactions and their effects on the body.*

FDA Label Image

Venlafaxine HCl Extended-release Capsules 375mg (Strength 1 30ct)

This text appears to be a description of Venlafaxine HCI Extended-Release capsules. The capsules contain 37.5mg of Venlafaxine Hydrochloride and are a generic version of Effexor ER. The medication is prescribed for a patient and it is important to store it at a temperature between 20-25°C. The batch and product details are provided along with a caution regarding the prohibition of transferring the drug to anyone other than the patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.